Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
9,042,979 7.500% |
2,546,386 (+39.20%) |
Filing History |
| 2025-02-14 11:24 am Purchase |
2024-12-31 | 13G | Avidity Biosciences, Inc. RNA |
JANUS HENDERSON GROUP PLC JHG |
7,053,010 5.900% |
7,053,010 (New Position) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
RA Capital Management, L.P. | 6,300,408 5.400% |
1,404,449 (+28.69%) |
Filing History |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
PRICE T ROWE ASSOCIATES INC | 10,633,962 9.000% |
977,110 (+10.12%) |
Filing History |
| 2024-11-14 09:39 am Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
AVORO CAPITAL ADVISORS LLC | 9,935,792 8.300% |
9,935,792 (New Position) |
Filing History |
| 2024-11-13 4:40 pm Sale |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
Cowen Financial Products LLC | 0 0.000% |
-5,629,103 (Position Closed) |
Filing History |
| 2024-11-13 4:05 pm Unchanged |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
BRISTOL MYERS SQUIBB CO BMY |
5,075,304 4.300% |
0 (Unchanged) |
Filing History |
| 2024-11-12 1:26 pm Unchanged |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
The Vanguard Group | 9,226,884 7.840% |
0 (Unchanged) |
Filing History |
| 2024-11-08 1:56 pm Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
WELLINGTON MANAGEMENT CO LLP | 7,030,949 5.970% |
7,030,949 (New Position) |
Filing History |
| 2024-11-04 10:22 am Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
The Vanguard Group | 9,226,884 7.840% |
5,183,705 (+128.21%) |
Filing History |
| 2024-08-23 5:46 pm Purchase |
2024-08-22 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 12,079,734 9.990% |
2,419,925 (+25.05%) |
Filing History |
| 2024-05-06 5:57 pm Purchase |
2024-04-26 | 13G | Avidity Biosciences, Inc. RNA |
RA Capital Management, L.P. | 4,895,959 5.100% |
2,441,426 (+99.47%) |
Filing History |
| 2024-03-11 1:12 pm Purchase |
2024-02-29 | 13G | Avidity Biosciences, Inc. RNA |
PRICE T ROWE ASSOCIATES INC | 9,656,852 12.100% |
2,738,942 (+39.59%) |
Filing History |
| 2024-03-01 4:15 pm Purchase |
2024-02-28 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 9,659,809 9.990% |
2,958,320 (+44.14%) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Avidity Biosciences, Inc. RNA |
RA Capital Management, L.P. | 2,454,533 3.300% |
-3,000,000 (-55.00%) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Avidity Biosciences, Inc. RNA |
PRICE T ROWE ASSOCIATES INC | 6,917,910 9.300% |
210,623 (+3.14%) |
Filing History |
| 2024-02-13 4:59 pm Purchase |
2023-12-29 | 13G | Avidity Biosciences, Inc. RNA |
The Vanguard Group | 4,043,179 5.460% |
572,553 (+16.50%) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 10,404,096 14.040% |
-218,767 (-2.06%) |
Filing History |
| 2024-02-02 12:08 pm Purchase |
2023-12-29 | 13G | Avidity Biosciences, Inc. RNA |
Cowen Financial Products LLC | 5,629,103 7.600% |
440,737 (+8.49%) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
6,496,593 8.800% |
1,210,419 (+22.90%) |
Filing History |